{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:02Z","timestamp":1740147302166,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11845-023-03560-x","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T17:02:09Z","timestamp":1699462929000},"page":"1589-1594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic plasma exchange in paediatric nephrology in Ireland"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6281-5713","authenticated-orcid":false,"given":"Dermot M.","family":"Wildes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caoimhe Suzanne","family":"Costigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Hensey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clodagh","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen Mary","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"3560_CR1","doi-asserted-by":"crossref","unstructured":"Reddy S, Jahan A, Chaturvedi S, Agarwal I (2015) Plasma exchange for paediatric kidney disease\u2014indications and outcomes: a single-centre experience. Clin Kidney J 8(6):702\u2013707. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4655793\/","DOI":"10.1093\/ckj\/sfv084"},{"key":"3560_CR2","doi-asserted-by":"crossref","unstructured":"Schwab P, Fahey J (1960) Treatment of Waldenstr\u00f6m\u2019s macroglobulinemia by plasmapheresis. N Engl J Med 263(12):574\u2013579. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1879704\/","DOI":"10.1056\/NEJM196009222631202"},{"key":"3560_CR3","doi-asserted-by":"crossref","unstructured":"Hans R, Sharma R, Marwaha N et al (2015) Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients. J Clin Apher 31(4):381\u2013387. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26212115\/","DOI":"10.1002\/jca.21412"},{"key":"3560_CR4","unstructured":"Fencl F, Vondrak K, Rosik T et al (2016) Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. Minerva Paediatr 68(5):348\u2013354. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26041001\/"},{"key":"3560_CR5","doi-asserted-by":"crossref","unstructured":"Sartain S, Shubert S, Wu M, Srivaths P et al (2019) Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy: an institutional experience. Biol Blood Marrow Transplant 25(1):157\u2013162. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30144562\/","DOI":"10.1016\/j.bbmt.2018.08.016"},{"key":"3560_CR6","doi-asserted-by":"crossref","unstructured":"Khandelwal P, Thomas C, Rathi B et al (2019) Membrane\u2010filtration based plasma exchanges for atypical hemolytic uremic syndrome: audit of efficacy and safety. J Clin Apher 34(5):555\u2013562. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31173399\/","DOI":"10.1002\/jca.21711"},{"issue":"1","key":"3560_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00467-014-2907-3","volume":"30","author":"F Paglialonga","year":"2015","unstructured":"Paglialonga F, Schmitt CP, Shroff R et al (2015) Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units. Pediatr Nephrol 30(1):103\u2013111. https:\/\/doi.org\/10.1007\/s00467-014-2907-3. Epub 2014 Aug 20 PMID: 25135618","journal-title":"Pediatr Nephrol"},{"key":"3560_CR8","doi-asserted-by":"crossref","unstructured":"Michon B, Moghrabi A, Winikoff R et al (2007) Complications of apheresis in children. Transfusion. 47(10):1837\u20131842. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17880609\/","DOI":"10.1111\/j.1537-2995.2007.01405.x"},{"issue":"2","key":"3560_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38(2):77\u2013278. https:\/\/doi.org\/10.1002\/jca.22043. PMID: 37017433","journal-title":"J Clin Apher"},{"key":"3560_CR10","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) (Version 5) [Internet]. Ctep.cancer.gov. 2020 [cited 9 September 2020]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"key":"3560_CR11","doi-asserted-by":"publisher","unstructured":"Goldstein SL (2012) Therapeutic apheresis in children: special considerations. Semin Dial 25(2):165\u201370. https:\/\/doi.org\/10.1111\/j.1525-139X.2011.01028.x. Epub 2012 Jan 25. PMID: 22277133","DOI":"10.1111\/j.1525-139X.2011.01028.x"},{"key":"3560_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","volume":"47","author":"B Michon","year":"2007","unstructured":"Michon B, Moghrabi A, Winikoff R et al (2007) Complications of apheresis in children. Transfusion 47:1837\u20131842. https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01405.x","journal-title":"Transfusion"},{"issue":"3","key":"3560_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/(sici)1098-1101(1999)14:3<114::aid-jca2>3.0.co;2-8","volume":"14","author":"GA Goss","year":"1999","unstructured":"Goss GA, Weinstein R (1999) Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium. J Clin Apher 14(3):114\u2013121. https:\/\/doi.org\/10.1002\/(sici)1098-1101(1999)14:3%3c114::aid-jca2%3e3.0.co;2-8. PMID: 10540365","journal-title":"J Clin Apher"},{"key":"3560_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04744-8","author":"C Joseph","year":"2020","unstructured":"Joseph C, Siddiqui S, Shah S et al (2020) Therapeutic plasma exchange: single-center experience in children with kidney disorders. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04744-8","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3560_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","volume":"34","author":"A Padmanabhan","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N et al (2019) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue. J Clin Apher 34(3):171\u2013354. https:\/\/doi.org\/10.1002\/jca.21705. PMID: 31180581","journal-title":"J Clin Apher"},{"key":"3560_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrneph.2012.196","volume":"8","author":"H Trachtman","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 8:658\u2013669","journal-title":"Nat Rev Nephrol"},{"key":"3560_CR17","first-page":"195","volume":"6","author":"LS Keir","year":"2012","unstructured":"Keir LS, Marks SD, Kim JJ (2012) Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther 6:195\u2013208","journal-title":"Drug Des Devel Ther"},{"key":"3560_CR18","doi-asserted-by":"crossref","unstructured":"Melton\u2010Celsa AR (2014) Shiga toxin (Stx) classification, structure, and function. Microbiol Spectr 2:10.1128","DOI":"10.1128\/microbiolspec.EHEC-0024-2013"},{"key":"3560_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/1744-9987.12768","volume":"23","author":"W Keenswijk","year":"2019","unstructured":"Keenswijk W, Raes A, De Clerck M, Vande Walle J (2019) Is plasma exchange efficacious in shiga toxin-associated hemolytic uremic syndrome? A narrative review of current evidence. Ther Apher Dial 23:118\u2013125. https:\/\/doi.org\/10.1111\/1744-9987.12768","journal-title":"Ther Apher Dial"},{"key":"3560_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(78)91573-8","volume":"2","author":"G Remuzzi","year":"1978","unstructured":"Remuzzi G, Misiani R, Marehesi D et al (1978) Haemolyticuraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 2:871\u2013872","journal-title":"Lancet"},{"key":"3560_CR21","doi-asserted-by":"crossref","unstructured":"Kielstein JT, Beutel G, Fleig S et al (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga\u2010toxin\u2010producing E. coli O104:H4 induced haemolytic\u2010uraemic syndrome: an analysis of the German STEC\u2010HUS registry. Nephrol Dial Transplant 27:3807e15","DOI":"10.1093\/ndt\/gfs394"},{"issue":"23","key":"3560_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368(23):2169\u20132181. https:\/\/doi.org\/10.1056\/NEJMoa1208981. PMID: 23738544","journal-title":"N Engl J Med"},{"key":"3560_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04200-1","author":"C Costigan","year":"2021","unstructured":"Costigan C, Raftery T, Carroll AG et al (2021) Neurological involvement in children with hemolytic uremic syndrome. Eur J Pediatr. https:\/\/doi.org\/10.1007\/s00431-021-04200-1","journal-title":"Eur J Pediatr"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03560-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T02:27:11Z","timestamp":1716776831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03560-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was provided by the CHI at Temple St, Research & Ethics committee (Approval number 21.027).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Professor Awan previously served on the Alexicon medical advisory board. All other authors declare that there are no relevant interests of a financial\/non-financial nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No informed consent was obtained as patients are non-identifiable from the presented data in this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}